• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用釉基质蛋白和引导组织再生技术治疗骨内缺损的十年随访结果

Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration.

作者信息

Sculean Anton, Kiss Alice, Miliauskaite Asta, Schwarz Frank, Arweiler Nicole B, Hannig Matthias

机构信息

Department of Periodontology, Radboud University Medical Center, Nijmegen, The Netherlands.

出版信息

J Clin Periodontol. 2008 Sep;35(9):817-24. doi: 10.1111/j.1600-051X.2008.01295.x. Epub 2008 Jul 21.

DOI:10.1111/j.1600-051X.2008.01295.x
PMID:18647201
Abstract

BACKGROUND

Surgery utilizing an enamel matrix protein derivative (EMD) or guided tissue regeneration (GTR) has been shown to promote periodontal regeneration.

AIM

To evaluate the 10-year results following treatment with EMD, GTR, EMD+GTR, and open flap debridement (OFD).

MATERIAL AND METHODS

Thirty-eight patients out of an initial group of 56 participants were treated with one of the four modalities. Results were evaluated before surgery, at 1 year, and at 10 years. Primary outcome variable was CAL change.

RESULTS

Treatment with EMD yielded a mean CAL gain of 3.4+/-1.0 mm (p<0.001) and 2.9+/-1.4 mm (p<0.001) at 1 and 10 years, respectively. GTR resulted in a mean CAL gain of 3.2+/-1.4 (p<0.001) at 1 year and 2.8+/-1.2 mm (p<0.001) at 10 years. Mean CAL gain in the EMD+GTR group was of 3.3+/-1.1 mm (p<0.001) and 2.9+/-1.2 mm (p<0.001) at 1 and 10 years, respectively. Treatment with OFD demonstrated a mean CAL gain of 2.0+/-1.2 mm (p<0.01) at 1 year and 1.8+/-1.1 mm (p<0.01) at 10 years. Compared with OFD, the three regenerative treatments resulted in statistically significant (p<0.05) higher CAL gain, at both 1 and 10 years. The CAL change between 1 and 10 years did not present statistically significant differences in any of the four groups.

CONCLUSION

The present results indicate that the clinical outcomes obtained with all four approaches can be maintained over a period of 10 years.

摘要

背景

利用釉基质蛋白衍生物(EMD)或引导组织再生(GTR)进行的手术已被证明可促进牙周组织再生。

目的

评估采用EMD、GTR、EMD + GTR及开放瓣清创术(OFD)治疗10年后的效果。

材料与方法

最初的56名参与者中有38名患者接受了这四种治疗方式中的一种。在手术前、1年及10年时对结果进行评估。主要结局变量为临床附着丧失(CAL)的变化。

结果

EMD治疗在1年和10年时的平均CAL增加分别为3.4±1.0毫米(p<0.001)和2.9±1.4毫米(p<0.001)。GTR在1年时的平均CAL增加为3.2±1.4(p<0.001),在10年时为2.8±1.2毫米(p<0.001)。EMD + GTR组在1年和10年时的平均CAL增加分别为3.3±1.1毫米(p<0.001)和2.9±1.2毫米(p<0.001)。OFD治疗在1年时的平均CAL增加为2.0±1.2毫米(p<0.01),在10年时为1.8±1.1毫米(p<0.01)。与OFD相比,这三种再生治疗在1年和10年时均导致CAL增加具有统计学显著差异(p<0.05)。在这四种治疗组中,1年至10年期间的CAL变化均无统计学显著差异。

结论

目前的结果表明,这四种治疗方法所获得的临床疗效在10年期间均可维持。

相似文献

1
Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration.使用釉基质蛋白和引导组织再生技术治疗骨内缺损的十年随访结果
J Clin Periodontol. 2008 Sep;35(9):817-24. doi: 10.1111/j.1600-051X.2008.01295.x. Epub 2008 Jul 21.
2
Five-year clinical results for treatment of intrabony defects with EMD, guided tissue regeneration and open-flap debridement: a case series.使用釉基质衍生物、引导组织再生术和开放式瓣清创术治疗骨内缺损的五年临床结果:病例系列
J Periodontal Res. 2015 Feb;50(1):123-30. doi: 10.1111/jre.12188. Epub 2014 May 12.
3
Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.使用引导组织再生术或釉基质衍生物治疗骨内缺损:一项为期3年的前瞻性随机临床研究。
J Periodontol. 2008 Dec;79(12):2281-9. doi: 10.1902/jop.2008.080135.
4
Four-year results of a prospective-controlled clinical study evaluating healing of intra-bony defects following treatment with an enamel matrix protein derivative alone or combined with a bioactive glass.一项前瞻性对照临床研究的四年结果,该研究评估单独使用釉基质蛋白衍生物或联合生物活性玻璃治疗后骨内缺损的愈合情况。
J Clin Periodontol. 2007 Jun;34(6):507-13. doi: 10.1111/j.1600-051X.2007.01084.x. Epub 2007 Apr 23.
5
Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial.采用釉基质衍生物或引导组织再生治疗非包裹性骨内缺损的临床疗效:一项为期 12 个月的随机对照临床试验。
J Periodontol. 2011 Jan;82(1):62-71. doi: 10.1902/jop.2010.100144. Epub 2010 Sep 1.
6
Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study.使用釉基质蛋白和引导组织再生治疗骨内缺损。一项前瞻性对照临床研究。
J Clin Periodontol. 2001 May;28(5):397-403. doi: 10.1034/j.1600-051x.2001.028005397.x.
7
Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.采用釉基质蛋白衍生物联合天然骨矿物质或 β-磷酸三钙治疗骨内缺损 10 年的疗效观察。
J Periodontol. 2013 Jun;84(6):749-57. doi: 10.1902/jop.2012.120238. Epub 2012 Aug 8.
8
Five-year results of a prospective, randomized, controlled study evaluating treatment of intra-bony defects with a natural bone mineral and GTR.一项评估天然骨矿物质与引导组织再生术治疗骨内缺损的前瞻性、随机、对照研究的五年结果。
J Clin Periodontol. 2007 Jan;34(1):72-7. doi: 10.1111/j.1600-051X.2006.01007.x.
9
Five-year results following treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration.使用釉基质蛋白和引导组织再生治疗骨内缺损的五年结果。
J Clin Periodontol. 2004 Jul;31(7):545-9. doi: 10.1111/j.1600-051X.2004.00518.x.
10
Treatment of intrabony defects with an enamel matrix protein derivative or bioabsorbable membrane: an 8-year follow-up split-mouth study.使用釉基质蛋白衍生物或生物可吸收膜治疗骨内缺损:一项8年随访的半口对照研究。
J Periodontol. 2006 Nov;77(11):1879-86. doi: 10.1902/jop.2006.060002.

引用本文的文献

1
Treatment of Stage III Grade C Periodontitis With Smoking Cessation Care and Periodontal Surgery Including Regenerative Therapy: A Case Report With a Two-Year Follow-Up.采用戒烟护理及包括再生治疗在内的牙周手术治疗Ⅲ期C级牙周炎:一例两年随访的病例报告
Cureus. 2025 Jun 6;17(6):e85449. doi: 10.7759/cureus.85449. eCollection 2025 Jun.
2
Long-Term Benefits of Periodontal Regeneration in Severely Compromised Teeth: A Retrospective Case Series.严重受损牙齿牙周组织再生的长期益处:一项回顾性病例系列研究
Case Rep Dent. 2025 Jun 16;2025:6925321. doi: 10.1155/crid/6925321. eCollection 2025.
3
Clinical Performance of the Bioperio Protocol to Manage Periodontitis.
用于治疗牙周炎的生物牙周治疗方案的临床疗效
J Clin Med. 2025 Mar 4;14(5):1738. doi: 10.3390/jcm14051738.
4
Reconstructive Approach in Residual Periodontal Pockets with Biofunctionalized Heterografts-A Retrospective Comparison of 12-Month Data from Three Centers.生物功能化异种移植物在残余牙周袋中的重建方法——来自三个中心的12个月数据回顾性比较
J Funct Biomater. 2024 Feb 9;15(2):39. doi: 10.3390/jfb15020039.
5
Enamel Matrix Derivative (EMD) as an Adjunct to Non-surgical Periodontal Therapy: A Systematic Review.釉基质衍生物(EMD)作为非手术牙周治疗的辅助手段:一项系统评价。
Cureus. 2023 Aug 15;15(8):e43530. doi: 10.7759/cureus.43530. eCollection 2023 Aug.
6
Affinity-selected heparan sulfate collagen device promotes periodontal regeneration in an intrabony defect model in Macaca fascicularis.亲和选择的硫酸乙酰肝素胶原蛋白装置促进食蟹猴牙槽骨内缺损模型中的牙周再生。
Sci Rep. 2023 Jul 21;13(1):11774. doi: 10.1038/s41598-023-38818-y.
7
Biomimetic Approaches in Clinical Endodontics.临床牙髓病学中的仿生方法。
Biomimetics (Basel). 2022 Dec 6;7(4):229. doi: 10.3390/biomimetics7040229.
8
Prognostic factors affecting periodontal regenerative therapy using recombinant human fibroblast growth factor-2: A 3-year cohort study.影响使用重组人成纤维细胞生长因子-2进行牙周再生治疗的预后因素:一项为期3年的队列研究。
Regen Ther. 2022 Aug 27;21:271-276. doi: 10.1016/j.reth.2022.07.006. eCollection 2022 Dec.
9
Periodontal granulation tissue preservation in surgical periodontal disease treatment: a pilot prospective cohort study.手术治疗牙周病时牙周肉芽组织的保存:一项前瞻性队列试验研究
J Periodontal Implant Sci. 2022 Aug;52(4):298-311. doi: 10.5051/jpis.2105780289.
10
Ten-Year Stability of Clinical Attachment after Regenerative Treatment of Infrabony Defects and Controls.骨下袋缺损再生治疗及对照后的临床附着十年稳定性
J Clin Med. 2022 Jan 21;11(3):543. doi: 10.3390/jcm11030543.